Terms: = Kidney tumors AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG
57 results:
1. Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY.
Pearce FA; Lim SH; Bythell M; Lanyon P; Hogg R; Taylor A; Powter G; Cooke GS; Ward H; Chilcot J; Thomas H; Mumford L; McAdoo SP; Pettigrew GJ; Lightstone L; Willicombe M
Lancet Rheumatol; 2023 Aug; 5(8):e461-e473. PubMed ID: 38251578
[TBL] [Abstract] [Full Text] [Related]
2. Serum cystatin C for risk stratification of prediabetes and diabetes populations.
Xiong K; Zhang S; Zhong P; Zhu Z; Chen Y; Huang W; Wang W
Diabetes Metab Syndr; 2023 Nov; 17(11):102882. PubMed ID: 37898064
[TBL] [Abstract] [Full Text] [Related]
3. Development and external validation of the multichannel deep learning model based on unenhanced CT for differentiating fat-poor angiomyolipoma from renal cell carcinoma: a two-center retrospective study.
Yao H; Tian L; Liu X; Li S; Chen Y; Cao J; Zhang Z; Chen Z; Feng Z; Xu Q; Zhu J; Wang Y; Guo Y; Chen W; Li C; Li P; Wang H; Luo J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15827-15838. PubMed ID: 37672075
[TBL] [Abstract] [Full Text] [Related]
4. Predictive value of CXCL10 for the occurrence of immune-related adverse events in patient with renal cell carcinoma.
Miura Y; Motoshima T; Anami T; Yano H; Mito R; Pan C; Urakami S; Kinowaki K; Tsukamoto H; Kurahashi R; Murakami Y; Yatsuda J; Fujiwara Y; Kamba T; Komohara Y
Microbiol Immunol; 2023 Jul; 67(7):345-354. PubMed ID: 36975091
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery.
Bakkila BF; Kerekes D; Nunez-Smith M; Billingsley KG; Ahuja N; Wang K; Oladele C; Johnson CH; Khan SA
JAMA Netw Open; 2022 Apr; 5(4):e225664. PubMed ID: 35377425
[TBL] [Abstract] [Full Text] [Related]
6. The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real-World Multi-Institutional Analysis.
Ghatalia P; Handorf EA; Geynisman DM; Deng M; Zibelman MR; Abbosh P; Anari F; Greenberg RE; Viterbo R; Chen D; Smaldone MC; Kutikov A; Uzzo RG
J Urol; 2022 Jul; 208(1):71-79. PubMed ID: 35212574
[TBL] [Abstract] [Full Text] [Related]
7. Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy.
Mizuno R; Takamatsu K; Yasumizu Y; Tanaka N; Takeda T; Morita S; Matsumoto K; Kosaka T; Asanuma H; Mikami S; Oya M
Urol Int; 2022; 106(11):1145-1149. PubMed ID: 35139522
[TBL] [Abstract] [Full Text] [Related]
8. Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors.
Seethapathy H; Street S; Strohbehn I; Lee M; Zhao SH; Rusibamayila N; Chute DF; Gao X; Michaelson MD; Rahma OE; Choueiri TK; McGregor B; Sonpavde G; Salabao C; Kaymakcalan MD; Wei X; Gupta S; Motwani S; Leaf DE; Reynolds KL; Sise ME
Eur J Cancer; 2021 Nov; 157():50-58. PubMed ID: 34482189
[TBL] [Abstract] [Full Text] [Related]
9. A meta-analysis of the influence of body mass index on the clinicopathologic progression of papillary thyroid carcinoma.
Cui N; Sun Q; Chen L
Medicine (Baltimore); 2021 Aug; 100(32):e26882. PubMed ID: 34397906
[TBL] [Abstract] [Full Text] [Related]
10. Warm ischemia time length during on-clamp partial nephrectomy: does it really matter?
Abdel Raheem A; Alowidah I; Capitanio U; Montorsi F; Larcher A; Derweesh I; Ghali F; Mottrie A; Mazzone E; DE Naeyer G; Campi R; Sessa F; Carini M; Minervini A; Raman JD; Rjepaj CJ; Kriegmair MC; Autorino R; Veccia A; Mir MC; Claps F; Choi YD; Ham WS; Tadifa JP; Santok GD; Furlan M; Simeone C; Bada M; Celia A; Carrión DM; Aguilera Bazan A; Ballesteros Ruiz C; Malki M; Barber N; Hussain M; Micali S; Puliatti S; Alwahabi A; Alqahtani A; Rumaih A; Ghaith A; Ghoneem AM; Hagras A; Eissa A; Alenzi MJ; Pavan N; Traunero F; Antonelli A; Porcaro AB; Illiano E; Costantini E; Rha KH
Minerva Urol Nephrol; 2022 Apr; 74(2):194-202. PubMed ID: 34308610
[TBL] [Abstract] [Full Text] [Related]
11. HLA-DR and cd74 Expression and the Immune Microenvironment in Renal Cell Carcinoma.
Miura Y; Anami T; Yatsuda J; Motoshima T; Oka S; Suyama K; Inoshita N; Kinowaki K; Urakami S; Kamba T; Komohara Y
Anticancer Res; 2021 Jun; 41(6):2841-2848. PubMed ID: 34083274
[TBL] [Abstract] [Full Text] [Related]
12. MR-Guided Microwave Ablation in T1 Renal Cell Carcinoma: Initial Results in Clinical Routine.
Li Z; Jiao DC; Wang C; Zhang W; Li J; Han X
Biomed Res Int; 2021; 2021():5537192. PubMed ID: 34055980
[TBL] [Abstract] [Full Text] [Related]
13. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
[TBL] [Abstract] [Full Text] [Related]
14. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
[TBL] [Abstract] [Full Text] [Related]
15. Risk of primary urological and genital cancers following incident breast cancer: a Danish population-based cohort study.
Sundbøll J; Farkas DK; Adelborg K; Schapira L; Tamang S; Nørgaard M; Cullen MR; Cronin-Fenton D; Sørensen HT
Breast Cancer Res Treat; 2020 Dec; 184(3):825-837. PubMed ID: 32845432
[TBL] [Abstract] [Full Text] [Related]
16. A comparative propensity score-matched analysis of perioperative outcomes of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Hussein AA; Elsayed AS; Aldhaam NA; Jing Z; Peabody JO; Wijburg CJ; Wagner A; Canda AE; Khan MS; Scherr D; Schanne F; Maatman TJ; Kim E; Mottrie A; Aboumohamed A; Gaboardi F; Pini G; Kaouk J; Yuh B; Rha KH; Hemal A; Palou Redorta J; Badani K; Saar M; Stockle M; Richstone L; Roupret M; Balbay D; Dasgupta P; Menon M; Guru KA
BJU Int; 2020 Aug; 126(2):265-272. PubMed ID: 32306494
[TBL] [Abstract] [Full Text] [Related]
17. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
[TBL] [Abstract] [Full Text] [Related]
18. Epidemiology and Outcome of Critically Ill Pediatric Cancer and Hematopoietic Stem Cell Transplant Patients Requiring Continuous Renal Replacement Therapy: A Retrospective Nationwide Cohort Study.
Raymakers-Janssen PAMA; Lilien MR; Tibboel D; Kneyber MCJ; Dijkstra S; van Woensel JBM; Lemson J; Cransberg K; van den Heuvel-Eibrink MM; Wösten-van Asperen RM;
Crit Care Med; 2019 Nov; 47(11):e893-e901. PubMed ID: 31464768
[TBL] [Abstract] [Full Text] [Related]
19. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
Palumbo C; Cyr SJ; Mazzone E; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI
J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
[No Abstract] [Full Text] [Related]
20. MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential.
Penticuff JC; Woolbright BL; Sielecki TM; Weir SJ; Taylor JA
Nat Rev Urol; 2019 May; 16(5):318-328. PubMed ID: 30914802
[TBL] [Abstract] [Full Text] [Related]
[Next]
